SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today ...
- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve ...
Notice of Allowance received and, once granted, the new U.S. patent is expected to ...
